Nuvectis Pharma sets up $200 million at-the-market equity program with Jefferies - NVCT News | RalliesNuvectis Pharma sets up $200 million at-the-market equity program with Jefferies
N
NVCT• At-the-market equity program
- Nuvectis Pharma set up an at-the-market equity offering program to sell common stock from time to time through Jefferies.
- Program to be conducted under a new Form S-3 shelf registration statement covering USD 200 million of securities.
- Jefferies to earn up to 3% of gross proceeds on shares sold under the sales agreement.
- Prior at-the-market program tied to a February 13, 2026 prospectus supplement was terminated on July 20, 2026.
